MitchMiller:
Just bought stock in the company that's taking it through FDA trials. Bought and sold, now bought again since it's 50% off it's 52 week high. It's recruiting for a phase IIB trial now. So far the only question marks are that there have been 2 subjects that have taken the drug where it had no or minimal effect. I have yet to see the company issue an explanation for this. Otherwise, it seems to be about as potent as the average NRTI. It looked really good in a study of treatment naive subjects. For more info go to www.panacos.com (symbol PANC)
J220:
Does anyone here know someone on the PA457 trial? I am wondering how it's going on the current phase, which started in June.